Tag: FDA
What Will the Coronavirus Reveal About Our Healthcare System?

Scientists, doctors, and citizens everywhere are debating how concerned we should be about the outbreak of Coronavirus, also known as COVID-19. With alarming headlines grabbing our attention, the World Health Organization has increased its assessment of the risk of spread and impact to “very high.” Catalyst Fellow Conor Norris has taken a look at…
Read More »

Who Should Regulate Tobacco Products? Less Is More!

Over the past year, the Food and Drug Administration undertook a “historic crackdown” of the e-cigarette industry. Recent bans on selected e-cigarette flavors are certainly a step in this direction. With promises for “aggressive action” by FDA Commissioner Stephen Hahn, more heavy-handed regulations are likely to follow. The FDA certainly has increased its regulatory…
Read More »

FDA Expands Ecstasy Access to Veterans with PTSD

In 2006, Johnathan Lubecky was deployed to Iraq. While fighting for his country, Johnathan faced constant enemy strikes, one of which resulted in a traumatic brain injury. Exposures to the horrors of war resulted in Johnathan developing post-traumatic stress disorder (PTSD).

Politicians Still Misunderstand High Insulin Prices

In 2015, the Centers for Disease Control ranked diabetes seventh among the leading causes of death in the United States. If current trends continue, skyrocketing death rates and other serious consequences of poorly managed diabetes will continue. Managing diabetes is challenging, often requiring strict dieting, regular exercise, and taking a variety of medications. For…
Read More »

Are More Vaping Bans Coming Soon? Let’s Hope Not!

Over the past year, the Food and Drug Administration has seemed determined to “wipe out the entire vaping industry.” As former FDA Commissioner Scott Gottlieb, who spearheaded much of the current anti-vaping movement,” notes: “the FDA is so concerned about the dangerous effects of e-cigarettes on American youth that the products may have to…
Read More »

Will FDA Approve Biogen’s Promising New Treatment for Alzheimer’s?

We’re only a few weeks into the new year, and the Food and Drug Administration will soon make a decision that will affect pharmaceutical regulation for decades. Last year, after failing an FDA-required futility test, Biogen abandoned its efforts to develop an Alzheimer’s treatment named aducanumab. However, after conducting an analysis using an expanded…
Read More »

New FDA Commissioner, Same FDA Problem

President Trump has nominated (and fired) numerous individuals to governmental positions while in office. Arguably, his most popular nominee was Food and Drug Administration Commissioner Scott Gottlieb. As a Modern Healthcare article notes, “Dr. Scott Gottlieb accomplished a rare feat during his two-year tenure as head of the Food and Drug Administration—he earned praise…
Read More »

Telemedicine Continues to Reach New Heights

Imagine you suddenly became injured and needed medical help quickly. How long would it take you to see a physician? For an increasing number of Americans, the answer may be concerning. According to a recent survey of 15 major metropolitan areas, wait times to see a physician for new patients increased by about 30…
Read More »

Breakthrough Alzheimer’s Drug Puts FDA’s Drug-Approval Process into Question

After many successful years as a corporate manager, Roger retired in his late sixties to spend more time with family. Three years into retirement, his once energetic and outgoing demeanor deteriorated, and he no longer found interest in things he once enjoyed. Concerned, his physician referred him to a psychiatrist. During his evaluation, Roger…
Read More »

Is Right-to-Try Legislation a Bust? Time for a Second Opinion.

In 2001, twenty-one-year-old Abigail Burroughs was dying of cancer. After all conventional treatment methods failed to improve her condition, Abigail’s oncologist pleaded with the Food and Drug Administration to allow her to try Erbitux. At the time, Erbitux had not fully passed the FDA’s drug approval process. Abigail was denied access and lost her…
Read More »

  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org